DSpace About DSpace Software 日本語

01 奈良県立医科大学 >
012 大学院 >
0122 学位請求論文 >
01221 博士論文(医学) >
2019年度 >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10564/3664

Title: Anti-inflammatory Effect of Ghrelin in Lymphoblastoid Cell Lines From Children With Autism Spectrum Disorder.
Other Titles: 自閉スペクトラム小児由来リンパ芽球様細胞株を用いたグレリンの抗炎症作用の検討
Authors: Yamashita, Yasunori
Makinodan, Manabu
Toritsuka, Michihiro
Yamauchi, Takahira
Ikawa, Daisuke
Kimoto, Sohei
Komori, Takashi
Takada, Ryohei
Kayashima, Yoshinori
Hamano-Iwasa, Kaori
Tsujii, Masatsugu
Matsuzaki, Hideo
Kishimoto, Toshifumi
Keywords: ghrelin
lymphoblastoid cell line
immune system
Issue Date: 26-Mar-2019
Publisher: Frontiers
Citation: Frontiers in psychiatry Vol.10 Articles No.152 (2019 Mar)
Abstract: The gut hormone ghrelin has been implicated in a variety of functional roles in the central nervous system through the brain-gut axis, one of which is an anti-inflammatory effect. An aberrant brain-gut axis producing immune dysfunction has been implicated in the pathobiology of autism spectrum disorder (ASD), and elevated expression of inflammatory markers has been shown in blood and brain tissue from subjects with ASD. We hypothesized that ghrelin may mitigate this effect. Lymphoblastoid cell lines from typically developed children (TD-C) (N = 20) and children with ASD (ASD-C) (N = 20) were cultured with PBS or human ghrelin (0.01 μM) for 24 h, and mRNA expression levels of the inflammation-related molecules interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and nuclear factor kappa B (NF-κB) were measured to examine the effects of ghrelin as an anti-inflammatory agent. Expression levels of TNF-α and NF-κB mRNA, but not IL-1β or IL-6, were significantly elevated in ASD-C compared to TD-C. Ghrelin showed a tendency to reduce the expression of TNF-α and NF-κB, but this was not statistically significant. Considering the heterogenous pathobiology of ASD, we examined the effects of ghrelin on TD-C and ASD-C with expression levels of TNF-α and NF-κB in the highest and lowest quartiles. We found that ghrelin markedly reduced mRNA expression of TNF-α and NF-κB s in ASD-C with highest-quartile expression, but there were no effects in ASD-C with lowest-quartile expression, TD-C with highest quartile expression, or TD-C with lowest quartile expression. Together, these findings suggest that ghrelin has potential as a novel therapeutic agent for ASD with inflammation and/or immune dysfunction.
Description: 博士(医学)・甲第719号・令和元年9月27日
Copyright © 2019 Yamashita, Makinodan, Toritsuka, Yamauchi, Ikawa, Kimoto, Komori, Takada, Kayashima, Hamano-Iwasa, Tsujii, Matsuzaki and Kishimoto. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
URI: http://hdl.handle.net/10564/3664
ISSN: 16640640
Academic Degrees and number: 24601A719
Degree-granting date: 2019-09-27
Degree name: 博士(医学)
Degree-granting institutions: 奈良県立医科大学
Appears in Collections:2019年度

Files in This Item:

File Description SizeFormat
01甲719本文の要旨.pdf甲719本文の要旨1.31 MBAdobe PDFView/Open
02甲719審査要旨.pdf甲719審査要旨876.98 kBAdobe PDFView/Open
03甲719本文.pdf甲719本文1.1 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback